Mesoblast Investor
%20.jpg)
Mesoblast is a medicine company that develops biologic products for the broad field of regenerative medicine.
.jpg)
Estimated Revenue:
$10M to $50M
Funding Status:
IPO
Industry:
Biotechnology, Health Care, Science and Engineering
Investors Number:
2
Last Funding Date:
2020-05-13
Number Of Exists:
1
Technology:
diagnostics
Founded Date:
2004-01-01
Investor Type:
N/A
Headquarters:
Australia
Total Funding:
227295275 USD
Last Funding Type:
Post-IPO Equity
Employee Number:
51-100
Investment Stage:
N/A